Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and pharmacokinetics of bimekizumab given in different administration methods in adults with psoriatic arthrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Psoriatic Arthritis, Axial Spondyloarthritis | Phase 1 | Status: RECRUITING